Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

30 Nov 2012 08:05

RNS Number : 3616S
Silence Therapeutics PLC
30 November 2012
 

 

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SILENCE THERAPEUTICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

X

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

ROBERT KEITH

4. Full name of shareholder(s)  (if different from 3.):iv

Rock (Nominees) Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30 November 2012

6. Date on which issuer notified:

30 November 2012

7. Threshold(s) that is/are crossed orreached: vi, vii

26%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0008433350

268,321,844

268,321,844

454,089,628

454,089,628

32,232,216

24.28%

1.83%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Spreadbet

n/a

n/a

n/a

 

34,232,216

Nominal

Delta

1.83%

1.83%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

488,321,844

26.11%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

ROBERT KEITH

15. Contact telephone number:

0207 491 0581

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKRNRUOAAUAA
Date   Source Headline
21st Mar 20127:00 amPRNUnaudited Preliminary Results
19th Mar 20127:00 amPRNNotification of Preliminary Results
10th Feb 20127:00 amPRNSilence Therapeutics Announces Board Changes and New CEO
27th Jan 20124:40 pmRNSSecond Price Monitoring Extn
27th Jan 20124:35 pmRNSPrice Monitoring Extension
26th Jan 20127:00 amPRNTR-1: Notifications of Major Interest in Shares
23rd Jan 20127:00 amPRNTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Jan 20127:00 amPRNSilence signs collaboration with miRagen Therapeutics
6th Jan 20127:00 amPRNResearch and Development Collaboration Update
30th Dec 20117:00 amPRNTotal Voting Rights
20th Dec 20114:40 pmRNSSecond Price Monitoring Extn
20th Dec 20114:35 pmRNSPrice Monitoring Extension
20th Dec 20117:00 amPRNAdditional Listing
12th Dec 20117:00 amPRNPositive Response by USPTO
9th Dec 20114:40 pmRNSSecond Price Monitoring Extn
9th Dec 20114:35 pmRNSPrice Monitoring Extension
7th Dec 20111:27 pmPRNPositive outcome from oral hearing at Patent Office
22nd Nov 20114:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20114:35 pmRNSPrice Monitoring Extension
8th Nov 20117:00 amPRNSilence Therapeutics provides update
24th Oct 20117:00 amPRNCollaboration with Mirna Therapeutics
14th Oct 20117:00 amPRNGrant of options
3rd Oct 20117:00 amPRNDirectors’ share purchases
21st Sep 20117:00 amPRNAppointment of Chief Business Officer
21st Sep 20117:00 amPRNInterim Results for the Six Months Ended 30 June 2011
20th Sep 20117:00 amPRNAppointment of Chief Executive Officer
14th Sep 201110:32 amPRNNotice of Results
13th Sep 20114:40 pmRNSSecond Price Monitoring Extn
13th Sep 20114:35 pmRNSPrice Monitoring Extension
12th Sep 20119:24 amPRNSilence & InteRNA Technologies collaboration
8th Sep 20114:40 pmRNSSecond Price Monitoring Extn
8th Sep 20114:35 pmRNSPrice Monitoring Extension
5th Sep 20114:40 pmRNSSecond Price Monitoring Extn
5th Sep 20114:35 pmRNSPrice Monitoring Extension
1st Sep 20114:40 pmRNSSecond Price Monitoring Extn
1st Sep 20114:35 pmRNSPrice Monitoring Extension
31st Aug 20114:40 pmRNSSecond Price Monitoring Extn
31st Aug 20114:35 pmRNSPrice Monitoring Extension
26th Aug 20114:40 pmRNSSecond Price Monitoring Extn
26th Aug 20114:35 pmRNSPrice Monitoring Extension
23rd Aug 20114:41 pmRNSSecond Price Monitoring Extn
23rd Aug 20114:35 pmRNSPrice Monitoring Extension
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension
18th Aug 20114:41 pmRNSSecond Price Monitoring Extn
18th Aug 20114:35 pmRNSPrice Monitoring Extension
12th Aug 20114:40 pmRNSSecond Price Monitoring Extn
12th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20114:40 pmRNSSecond Price Monitoring Extn
11th Aug 20114:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.